A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
The primary objective of this study is to determine the effect of treatment with AGA2118 versus placebo at Month 12 on lumbar spine bone mineral density (BMD) in postmenopausal women with low bone mas...
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Women at risk for development of breast cancer and experiencing vasomotor menopausal symptoms (hot flashes) will be randomized to bazedoxifene (BZA) plus conjugated estrogens (CE) for 6 months versus ...
Top Cities for Menopause Clinical Trials
Menopause clinical trials are recruiting across 14 cities. Here are the cities with the most active studies:
About Menopause
Menopause marks the end of menstrual cycles, typically occurring in the late 40s to early 50s, and brings symptoms like hot flashes, mood changes, and bone loss. The menopausal transition can last several years. Management includes hormone replacement therapy, non-hormonal medications, and lifestyle changes.
Clinical trials are advancing new treatments for menopause. Currently, 2 studies are recruiting a combined 470 participants across the United States. Research is being conducted by 2 organizations including Angitia Biopharmaceuticals, University of Kansas Medical Center.
2026 Menopause Research Landscape
As of March 2026, the menopause clinical trial landscape includes 2 actively recruiting studies across 14 cities in the United States. These studies are collectively seeking 470 participants, with an average enrollment target of 235 per study.
Research is being led by 2 different organizations, including Angitia Biopharmaceuticals, University of Kansas Medical Center.
Geographically, menopause trials are most concentrated in Buenos Aires, Argentina (2 trials); Birmingham, Alabama (1 trial); Tucson, Arizona (1 trial); Gainesville, Georgia (1 trial); Cumberland, Maryland (1 trial) and 7 other cities.
Featured Menopause Studies
Highlighted recruiting studies for menopause, selected by enrollment size and research scope.
A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)
The primary objective of this study is to determine the effect of treatment with AGA2118 versus placebo at Month 12 on lumbar spine bone mineral density (BMD) in postmenopausal women with low bone mass.
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
Women at risk for development of breast cancer and experiencing vasomotor menopausal symptoms (hot flashes) will be randomized to bazedoxifene (BZA) plus conjugated estrogens (CE) for 6 months versus a wait list control. Two risk factors for development of breast cancer will be studied pre-study and after 6 months: fibroglandular volume (FGV) on mammogram as assessed by Volpara software and prolif...
Frequently Asked Questions About Menopause Clinical Trials
Are there menopause clinical trials near me?
Yes, there are 2 menopause clinical trials currently recruiting across 14+ cities in the United States, including Buenos Aires, Argentina; Birmingham, Alabama; Tucson, Arizona. Browse the studies above to find one at a location convenient for you.
How do I join a menopause clinical trial?
To join a menopause clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are menopause clinical trials free?
Yes, participation in menopause clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of menopause treatments are being studied?
Current menopause clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in menopause clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov